2025
$0.71
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$7,439K; dWC (cash effect)=$-98K; SBC=$404K; capex=$42K, growth capex=$23.8K (capex ratio 0.1400% x revenue change $16989K) so maintenance capex=$18.2K; OE=$7,114.8K; diluted shares=9,977K (current split basis); OE/sh=$0.7131. WC = AR 210; inv (582); prepaid 200; AP 743; taxes payable (54); accrued (582); returns (33). Non-cash incl. inventory step-up 1,045, deferred tax (881), ROU 242/lease (223). Includes $2,075K Irwin transaction costs and ~5 months of Irwin (acquired 8-Aug-2025). Source: FY2025 10-K, accession 0001437749-26-010680.
2024
$0.93
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$9,610K; dWC (cash effect)=$-75K; SBC=$459K; capex=$10K, growth capex=$16.5K (capex ratio 0.1400% x revenue change $11769K) so maintenance capex=$0.0K; OE=$9,226K; diluted shares=9,898K (current split basis); OE/sh=$0.9321. WC = AR 361; inv (2,109); prepaid 692; AP 866; taxes payable 634; accrued (512); returns (7). Deferred tax 148, ROU 90 and lease (107) treated as non-cash. Source: FY2025 10-K, accession 0001437749-26-010680.
2023
$0.68
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$4,220K; dWC (cash effect)=$-2,966K; SBC=$473K; capex=$106K, growth capex=$33.5K (capex ratio 0.1400% x revenue change $23897K) so maintenance capex=$72.5K; OE=$6,640.5K; diluted shares=9,810K (current split basis); OE/sh=$0.6769. WC = AR (882); inv 1,026; prepaid (178); AP (2,679); taxes payable (356); accrued 122; returns (19). Non-cash incl. deferred tax 957 (NOL usage) and inventory step-up 323. MRC (Feb-2023) and MusclePharm (Oct-2023) acquired this year. Source: FY2024 10-K, accession 0001437749-25-009469.
2022
$0.58
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$4,130K; dWC (cash effect)=$-1,972K; SBC=$363K; capex=$0K, growth capex=$1.2K (capex ratio 0.1400% x revenue change $890K) so maintenance capex=$0.0K; OE=$5,739K; diluted shares=9,949K (current split basis); OE/sh=$0.5768. WC = AR 247; inv (2,636); prepaid 204; AP 115; accrued 140; returns (42). Deferred tax 1,199 (NOL usage) treated as non-cash. Shares = 4,975K reported x2. Source: FY2022 10-K, accession 0001437749-23-007858.
2021
$0.66
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$4,480K; dWC (cash effect)=$-2,286K; SBC=$452K; capex=$0K, growth capex=$8.1K (capex ratio 0.1400% x revenue change $5802K) so maintenance capex=$0.0K; OE=$6,314K; diluted shares=9,603K (current split basis); OE/sh=$0.6575. WC = AR 974; inv (2,945); prepaid (270); tax receivable 40; AP (366); accrued (6); returns 287. Non-cash incl. deferred tax 1,294 (NOL usage) and PPP forgiveness (453). Shares = 4,801K reported x2. Source: FY2022 10-K, accession 0001437749-23-007858.
2020
$0.49
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$5,721K; dWC (cash effect)=$1,168K; SBC=$78K; capex=$0K, growth capex=$4.2K (capex ratio 0.1400% x revenue change $2975K) so maintenance capex=$0.0K; OE=$4,475K; diluted shares=9,099K (current split basis); OE/sh=$0.4918. Restated 2020. NI $8,825K includes $4,339K non-cash deferred-tax valuation allowance release, removed within CFO. WC = AR (104); inv (97); prepaid 20; tax receivable (40); deposit 10; AP 1,228; accrued 72; returns 79. Shares = 4,549K reported x2. Source: FY2021 10-K (restated 2020), accession 0001851734-22-000612.
2019
$0.31
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$2,261K; dWC (cash effect)=$-587K; SBC=$182K; capex=$0K, growth capex=$2.9K (capex ratio 0.1400% x revenue change $2059K) so maintenance capex=$0.0K; OE=$2,666K; diluted shares=8,738K (current split basis); OE/sh=$0.3051. CFO unchanged by restatement; NI restated to $2,610K (from $2,698K); WC derived as CFO - NI - non-cash items (D&A 52, doubtful (17), obsolescence 23, SBC 182, ROU (2)). Shares = 1,092K reported x8 (2021 4:1, 2025 2:1). Source: FY2020 10-K/A, accession 0001851734-22-000611 (restated NI $2,610K); line items FY2019 10-K 0001654954-20-003419.
2018
$0.06
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$258K; dWC (cash effect)=$-602K; SBC=$293K; capex=$0K, growth capex=$0 (revenue declined) so maintenance capex=$0.0K; OE=$567K; diluted shares=8,755K (current split basis); OE/sh=$0.0648. WC = AR 1,334; inventories (707); prepaid (2); customer note 5; deposits 12; AP (346); accrued (192); product returns (706) per FY2019 10-K presentation. SBC = $163K stock + $130K options. Shares = 10,944K reported x0.8. Source: FY2019 10-K, accession 0001654954-20-003419.
2017
-$0.35
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$665.8K; dWC (cash effect)=$3,301.1K; SBC=$140.2K; capex=$185.1K, growth capex=$0 (revenue declined) so maintenance capex=$185.1K; OE=$-2,960.5K; diluted shares=8,415K (current split basis); OE/sh=$-0.3518. NI $(9,762)K incl. $5,929K goodwill/intangible impairment (non-cash, added back in CFO). WC includes $1,097K allowance for sales returns/doubtful accts and $120K prepaid income tax. SBC = $96.0K stock + $44.2K options. Deferred tax $689K treated as non-cash. Shares = 10,518K reported x0.8. Revenue fell 30% (GNC channel decline). Source: FY2017 10-K, accession 0001654954-18-004031.
2016
$0.11
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$48.2K; dWC (cash effect)=$-1,074.0K; SBC=$211.2K; capex=$23.4K, growth capex=$10.3K (capex ratio 0.1400% x revenue change $7382K) so maintenance capex=$13.1K; OE=$897.9K; diluted shares=8,272K (current split basis); OE/sh=$0.1085. WC = CF-statement changes in AR, inventories, allowance for sales returns/doubtful accts, prepaid income tax, prepaid, customer note, deposits, AP, accrued. SBC = stock issued for services $153.0K + options $58.2K. Shares = 10,340K reported x0.8 (2019 1-for-10 net reverse/forward split, 2021 4:1 and 2025 2:1 forward splits). Source: FY2017 10-K, accession 0001654954-18-004031.
Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.